Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| R01-15772-1 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to test a novel distance-based (telephone) intervention to help transplant candidates with current or recent substance abuse to stay "clean and sober" both prior and following transplant surgery.
Participants who need a liver or renal transplant and who are ineligible due to current or recent (past 6 months) alcohol and/or other drug abuse are being recruited from the transplant programs at St. Luke's-Roosevelt Hospital Center (renal), Columbia Presbyterian Hospital (renal/liver) and Virginia Commonwealth University Medical Center (liver). Baseline and follow-up computer-assisted assessments and structured clinical interviews along with collection of biological samples (urine, hair) will occur in the transplant clinics; however, phone counseling sessions originate at St. Luke's. Participants are randomly assigned to one of two treatments: (1) usual care (no phone counseling) or (2) usual care + counseling. The telephone counseling sessions are designed to help participants become motivated to remain abstinent and improve other health behaviors such as sleep or stress management.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| TAP | Experimental | MI-based phone intervention. |
|
| TAU | Other | Treatment As Usual |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| TAP | Behavioral | 12-session motivational interviewing-based telephone intervention. |
| |
| Measure | Description | Time Frame |
|---|---|---|
| Abstinence | 3 month time frame |
| Measure | Description | Time Frame |
|---|---|---|
| Stage of Change, illness response, psychological stress | 3 month time frame |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Deborah Haller | St. Luke's Roosevelt Hosp Cntr (New York) | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Behavioral Science Research Unit | New York | New York | 10025 | United States | ||
| Renal & Islet Transplant, Center for Liver Disease |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 24226847 | Background | Wagner CC, Haller DL, Olbrisch ME. Relapse prevention treatment for liver transplant patients. J Clin Psychol Med Settings. 1996 Dec;3(4):387-98. doi: 10.1007/BF01994021. | |
| Background | Presented at the Ninth Annual International Liver Transplantation Society Congress, Barcelona, Spain, June 2003. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D058625 | End Stage Liver Disease |
| D007676 | Kidney Failure, Chronic |
| D019966 | Substance-Related Disorders |
| ID | Term |
|---|---|
| D017093 | Liver Failure |
| D048550 | Hepatic Insufficiency |
| D008107 | Liver Diseases |
| D004066 | Digestive System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| TAU |
| Other |
The usual care group will receive the same medical services they would otherwise receive if they were not in this study. |
|
| New York |
| New York |
| 10032 |
| United States |
| Liver Transplant Program | Richmond | Virginia | 23298 | United States |
| D051436 |
| Renal Insufficiency, Chronic |
| D051437 | Renal Insufficiency |
| D007674 | Kidney Diseases |
| D014570 | Urologic Diseases |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D052801 | Male Urogenital Diseases |
| D002908 | Chronic Disease |
| D020969 | Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D064419 | Chemically-Induced Disorders |
| D001523 | Mental Disorders |